1. 1) Veronese FM. Peptide and protein PEGylation: a review of problems and solutions. Biomaterials, 22, 405–417 (2001).
2. 2) Abuchowski A, McCoy JR, Palczuk NC, van Es T, Davis FF. Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase. J. Biol. Chem., 252, 3582–3586 (1977).
3. 3) Levy Y, Hershfield MS, Fernandez-Mejia C, Polmar SH, Scudiery D, Berger M, Sorensen RU. Adenosine deaminase deficiency with late onset of recurrent infections: response to treatment with polyethylene glycol-modified adenosine deaminase. J. Pediatr., 113, 312–317 (1988).
4. 4) Graham ML. Pegaspargase: a review of clinical studies. Adv. Drug Deliv. Rev., 55, 1293–1302 (2003).
5. 5) Wang YS, Youngster S, Grace M, Bausch J, Bordens R, Wyss DF. Structural and biological characterization of pegylated recombinant interferon alpha-2b and its therapeutic implications. Adv. Drug Deliv. Rev., 54, 547–570 (2002).